Vimpat (lacosamide) Now Approved by FDA for Primary Generalized Tonic-Clonic Seizures and Expanded Pediatric Use for People Living with Epilepsy

Vimpat (lacosamide) Now Approved by FDA for Primary Generalized Tonic-Clonic Seizures and Expanded Pediatric Use for People Living with Epilepsy

ATLANTA, Nov. 17, 2020 /PRNewswire/ — UCB, a global pharmaceutical company, today announced th...
read more
Epilepsy Meds During Pregnancy May Raise Autism Risk in Child

Epilepsy Meds During Pregnancy May Raise Autism Risk in Child

FRIDAY, Oct. 30, 2020 — Women who take the e...
read more
Advancing science for children with epilepsy and movement disorders

Advancing science for children with epilepsy and movement disorders

Two Michigan State University College of Osteopath...
read more
Man accused of beating wife after she shared photos to raise epilepsy awareness

Man accused of beating wife after she shared photos to raise epilepsy awareness

A woman who shared photos of her seizure injuries ...
read more
Trigger region found for absence epileptic seizures

Trigger region found for absence epileptic seizures

Scientists have discovered a neurological origin f...
read more